— Know what they know.
Not Investment Advice

STSN OTC

Stemsation International, Inc.
1W: +22.7% 1M: -3.3% 3M: +228.3% YTD: +480.0% 1Y: +185.2% 3Y: +45.0% 5Y: -33.6%
$0.02
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $1.5M mcap · 30M float · 1.04% daily turnover · Short 78% of daily vol

Balance Sheet Trends

Total Assets
$13M +30105.8% ▲
5Y CAGR: +148.6%
Total Liabilities
$2M +111.1% ▲
5Y CAGR: +53.2%
Shareholders Equity
$11M +1779.4% ▲
Cash & Investments
$4K +364.6% ▲
5Y CAGR: -28.1%
Total Debt
$1M +284.9% ▲
5Y CAGR: +91.4%
Net Debt
$1M +284.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$18K$10K$10K$961$4K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$18K$10K$10K$961$4K
Net Receivables$0$167$0$0$0
Inventory$62K$0$0$0$0
Other Current Assets$0$62K$42K$42K$42K
Total Current Assets$80K$79K$59K$43K$389K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$13M
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$13M
Total Assets$80K$79K$59K$43K$13M
— Liabilities —
Accounts Payable$204K$66K$93K$83K$87K
Short-Term Debt$35K$214K$461K$282K$1M
Deferred Revenue$3K$0$0$0$0
Other Current Liabilities$4K$627K$358K$360K$358K
Total Current Liabilities$246K$908K$912K$725K$2M
Long-Term Debt$64K$0$0$0$0
Other Non-Current Liab.$0$69K$0$0$0
Total Non-Current Liabilities$64K$69K$0$0$0
Total Liabilities$311K$977K$912K$725K$2M
— Equity —
Common Stock$21K$19K$19K$25K$62K
Retained Earnings-$4M-$5M-$5M-$5M-$6M
Accumulated OCI$220$4K$86$9K$9K
Total Stockholders Equity-$230K-$898K-$853K-$682K$11M
Total Liabilities & Equity$80K$79K$59K$43K$13M
— Key Metrics —
Total Debt$99K$214K$461K$282K$1M
Net Debt$82K$214K$451K$281K$1M
Total Investments$0$0$0$0$13M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms